Bioavailability and Metabolism of Resveratrol

Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology

Volumn , Issue , 2009, Pages 265-297

  Andres Lacueva, Cristina ^a   Urpi Sarda, Mireia ^a   Zamora Ros, Raul ^a   Lamuela Raventos, Rosa M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bioavailability and resveratrol metabolism; Metabolism of piceid, as glucoside of resveratrol; Resveratrol metabolism in vivo in animal models

Indexed keywords

EID: 84889612175     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470531792.ch13     Document Type: Chapter

References (48)

1. Andlauer W, Kolb J, Siebert K, Furst P. 2000. Assessment of resveratrol bioavailability in the perfused small intestine of the rat. Drugs Exp Clin Res 26:47-55.
2. Asensi M, Medina I, Ortega A, Carretero J, Bano MC, Obrador E, Estrela J. 2002. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33:387-398.
3. Aumont V, Krisa S, Battaglia E, Netter P, Richard T, Merillon JM, Magdalou J, Sabolovic N. 2001. Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. Arch Biochem Biophys 393:281-289.
4. Barthe L, Woodley J, Houin G. 1999. Gastrointestinal absorption of drugs: Methods and studies. Fundam Clin Pharmacol 13:154-168.
5. Barthe L, Woodley JF, Kenworthy S Houin G. 1998. An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. Eur J Drug Metab Pharmacokinet 23:313-323.
6. Bertelli AA, Giovannini L, Stradi R, Bertelli A, Tillement JP. 1996. Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4u,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int J Tissue React 18:67-71.
7. Blache D, Rustan I, Durand P, Lesgards G, Loreau N. 1997. Gas chromatographic analysis of resveratrol in plasma, lipoproteins and cells after in vitro incubations. J Chromatogr B Biomed Sci Appl 702:103-110.
8. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE. 2007. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16:1246-1252.
9. Brill SS, Furimsky AM, Ho MN, Furniss MJ, Li Y, Green AG, Bradford WW, Green CE, Kapetanovic IM, Iyer LV. 2006. Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms. J Pharm Pharmacol 58:469-479.
10. Burkon A, Somoza V. 2008. Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides-Two novel resveratrol metabolites in human plasma. Mol Nutr Food Res 52:549-557.
11. Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. 2002. Plant foods and herbal sources of resveratrol. J Agric Food Chem 50:3337-3340.
12. Chen X, He H, Wang G, Yang B, Ren W, Ma L, Yu Q. 2007. Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: Application to pharmacokinetic studies. Biomed Chromatogr 21:257-265.
13. de Andrés-de Prado R, Yuste-Rojas M, Sort X, Andres-Lacueva C, Torres M, Lamuela-Raventos RM. 2007. Effect of soil type on wines produced from Vitis vinifera L. cv. Grenache in commercial vineyards. J Agric Food Chem 55:779-786.
14. de Santi C, Pietrabissa A, Mosca F, Pacifici GM. 2000a. Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 30:1047-1054.
15. de Santi C, Pietrabissa A, Spisni R, Mosca F, Pacifici GM. 2000b. Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica 30:609-617.
16. El-Mohsen M, Bayele H, Kuhnle G, Gibson G, Debnam E, Kaila SS, Rice-Evans C, Spencer JP. 2006. Distribution of [3H]trans-resveratrol in rat tissues following oral administration. Br J Nutr 96:62-70.
17. Goldberg DM, Yan J, Soleas GJ. 2003. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36:79-87.
18. Gonthier MP, Cheynier V, Donovan JL, Manach C, Morand C, Mila I, Lapierre C, Remesy C, Scalbert A. 2003. Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J Nutr 133:461-467.
19. González-Barrio R, Beltran D, Cantos E, Gil MI, Espín JC, Tomás-Barberán FA. 2006. Comparison of ozone and UV-C treatments on the postharvest stilbenoid monomer, dimer, and trimer induction in var. "Superior" white table grapes. J Agric Food Chem 54:4222-4228.
20. Henry C, Vitrac X, Decendit A, Ennamany R, Krisa S, Merillon JM. 2005. Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells. J Agric Food Chem 53:798-803.
21. Henry-Vitrac C, Desmouliere A, Girard D, Merillon JM, Krisa S. 2006. Transport, deglycosylation, and metabolism of trans-piceid by small intestinal epithelial cells. Eur J Nutr 45:376-382.
22. Huang H, Zhang J, Chen G, Lu Z, Wang X, Sha N, Shao B, Li P, Guo DA. 2008. High performance liquid chromatographic method for the determination and pharmacokinetic studies of oxyresveratrol and resveratrol in rat plasma after oral administration of Smilax china extract. Biomed Chromatogr 22:421-427.
23. Juan ME, Buenafuente J, Casals I, Planas JM. 2002. Plasmatic levels of trans-resveratrol in rats. Food Res Int 35:195-199.
24. Kaldas MI, Walle UK, Walle T. 2003. Resveratrol transport and metabolism by human intestinal Caco-2 cells. J Pharm Pharmacol 55:307-312.
25. Kuhnle G, Spencer JPE, Chowrimootoo G, Schroeter H, Debnam ES, Srai SKS, Rice-Evans C, Hahn U. 2000. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun 272:212-217.
26. Lv C, Zhang L, Wang Q, Liu W, Wang C, Jing X, Liu Y. 2006. Determination of piceid in rat plasma and tissues by high-performance liquid chromatographic method with UV detection. Biomed Chromatogr 20:1260-1266.
27. Maier-Salamon A, Hagenauer B, Wirth M, Gabor F, Szekeres T, Jager W. 2006. Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites. Pharm Res 23:2107-2115.
28. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. 2002. Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302:369-373.
29. Meng X, Maliakal P, Lu H, Lee MJ, Yang CS. 2004. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J Agric Food Chem 52:35-942.
30. Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. 2004. Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem 52:4713-4719.
31. Romero-Perez AI, Lamuela-Raventos RM, Andres-Lacueva C, Torre-Boronat MC. 2001. Method for the quantitative extraction of resveratrol and piceid isomers in grape berry skins. Effect of powdery mildew on the stilbene content. J Agric Food Chem 49:210-215.
32. Roupe KA, Yáñez JA, Teng XW, Davies NM. 2006. Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats. J Pharm Pharmacol 58:1443-1450.
33. Sale S, Verschoyle RD, Boocock D, Jones DJ, Wilsher N, Ruparelia KC, Potter GA, Farmer PB, Steward WP, Gescher AJ. 2004. Pharmacokinetics in mice and growthinhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4u-tetramethoxystilbene. Br J Cancer 90:736-744.
34. Sobolev VS, Cole RJ. 1999. trans-Resveratrol content in commercial peanuts and peanut products. J Agric Food Chem 47:1435-1439.
35. Soleas GJ, Angelini M, Grass L, Diamandis EP, Goldberg DM. 2001a. Absorption of trans-resveratrol in rats. Methods Enzymol 335:145-154.
36. Soleas GJ, Yan J, Goldberg DM. 2001b. Ultrasensitive assay for three polyphenols (catechin, quercetin and resveratrol) and their conjugates in biological fluids utilizing gas chromatography with mass selective detection. J Chromatogr B Biomed Sci Appl 757:161-172.
37. Tokusoglu O, Unal MK, Yemis F. 2005. Determination of the phytoalexin resveratrol (3,5,4u-trihydroxystilbene) in peanuts and pistachios by high-performance liquid chromatographic diode array (HPLC-DAD) and gas chromatography-mass spectrometry (GC-MS). J Agric Food Chem 53:5003-5009.
38. Urpi-Sarda M, Zamora-Ros R, Lamuela-Raventós RM, Cherubini A, Jauregui O, de la Torre R, Covas M, Estruch R, Jaeger W, Andres-Lacueva C. 2007. HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans. Clin Chem 53:292-299.
39. Urpi-Sarda M, Jauregui O, Lamuela-Raventós RM, Jaeger W, Miksits M, Covas M, Andres-Lacueva C. 2005. Uptake of diet resveratrol into the human low density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Anal Chem 77:3149-3155.
40. Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R. 2005. Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res 49:495-504.
41. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Merillon JM. 2003. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72:2219-2233.
42. Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377-1382.
43. Wang D, Hang T, Wu C, Liu W. 2005. Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 829:97-106.
44. Wenzel E, Soldo T, Erbersdobler H, Somoza V. 2005. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats1847. Mol Nutr Food Res 49:482-494.
45. Yu C, Shin YG, Chow A, Li Y, Kosmeder, JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB. 2002. Human, rat, and mouse metabolism of resveratrol. Pharm Res 19:1907-1914.
46. Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventós RM, Berenguer T, Jakszyn P, Martínez C, Sánchez MJ, Navarro C, Chirlaque MD, Tormo MJ, Quirós JR, Amiano P, Dorronsoro M, Larrañaga N, Barricarte A, Ardanaz E, González CA. 2008. Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. Br J Nutr 100:188-196.
47. Zamora-Ros R, Urpi-Sarda M, Lamuela-Raventós RM, Estruch R, Vázquez-Agell M, Serrano-Martínez M, Jaeger W, Andres-Lacueva C. 2006. Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption. Clin Chem 52:1373-1380.
48. Zhou M, Chen X, Zhong D. 2007. Simultaneous determination of trans-resveratrol-3-Oglucoside and its two metabolites in rat plasma using liquid chromatography with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci 854:219-223.